BioTuesdays

Mass. Life Sciences launches ramp-up program

The Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) has launched the Massachusetts Ramp-Up Program (MassRamp), a new program that will provide grant funding to promising early-stage life sciences companies.

The program will provide supplemental grant funding, on a competitive basis, to companies that have been awarded Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Phase 1 grants or contracts from federal agencies.

MassRamp aims to bridge the funding gaps associated with the long life sciences R&D cycle, and the high cost of translating research into commercially viable products. Up to $3-million in funding is available for the inaugural round of the program.

MLSC will provide grants of up to $300,000 to help early-stage companies cover the costs of direct labor, clinical trials, consultants and subcontractors, materials, supplies and equipment.

The award is designed to support activities not covered by a federal grant, provide additional resources to complement an approved federal project, or expand the scope of a federal grant, provided that the MassRamp proposal is based on the same technology approved in the federal award.

“Our young, dynamic companies are a wellspring of innovation that represent future IPOs and serve as a magnet for larger companies seeking strategic partnerships and acquisitions,” Travis McCready, president and CEO of MLSC, said in a statement.

“MLSC designed MassRamp to help sustain companies with early validation of technologies through what can be a tumultuous stage of research and development,” he added. “Our awards will help them leverage additional sources of capital to bring cutting edge innovation to the marketplace.”

POWERED BY

Stay Ahead in Healthcare & Life Sciences